Medicenna Therapeutics Stock Quote MDNA - Stock Price, News, Charts, Message Board, Trades

Unlock more advanced trading tools

Join ADVFN today

Current Price

0.157

Bid

0.1565

Ask

0.1612

Volume

0.00 Day's Range 0.00

0.151251 52 Week Range 0.7801

Market Cap

169.914M

Previous Close

0.157

Open

Last Trade

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

Shares Outstanding

69,637,000

Dividend Yield

PE Ratio

-16.91

Earnings Per Share (EPS)

-0.14

Revenue

Net Profit

-10.05M

Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically ... Medicenna Therapeutics Corp is a Canada based immuno-oncology company. Its principal business activity is the development and commercialization of Empowered Cytokines and Superkines for the treatment of cancer. The company is engaged in developing Interleukin-4 Empowered Cytokines that specifically target the Interleukin-4 Receptor which is over-expressed by 20 different cancers, cancer stem cells and immunosuppressive cells of the tumor microenvironment. The have the potential to purge the tumor and un-blind the immune system to cancer thereby altering the treatment paradigm for a large majority of cancer patients. Show more

Sector

Biological Pds,ex Diagnstics

Industry

Biological Pds,ex Diagnstics

Website

www.medicenna.com

Headquarters

Toronto, Ontario, Can

Founded

1970

Medicenna Therapeutics Corporation is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MDNA. The last closing price for Medicenna Therapeutics was $0.16. Over the last year, Medicenna Therapeutics shares have traded in a share price range of $ 0.151251 to $ 0.7801.

Medicenna Therapeutics currently has 69,637,000 shares outstanding. The market capitalization of Medicenna Therapeutics is $169.91 million. Medicenna Therapeutics has a price to earnings ratio (PE ratio) of -16.91.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0	0	0	0	0	CS
4	0	0	0	0	0	0	0	CS
12	0	0	0	0	0	0	0	CS
26	0	0	0	0	0	0	0	CS
52	-0.593	-79.0666666667	0.75	0.7801	0.151251	201239	0.36086884	CS
156	-3.153	-95.2567975831	3.31	4.06	0.151251	162852	1.18875372	CS
260	-4.473	-96.6090712743	4.63	6.84	0.151251	161652	1.81954177	CS

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
NUVOHoldco Nuvo Group DG Ltd	$ 5.2108 (155.43%)	43.44M
XBPXBP Europe Holdings Inc	$ 3.4999 (65.09%)	55.73M
PLTNPlutoniam Acquisition Corporation	$ 9.40 (56.41%)	1.43M
PRFTPerficient Inc	$ 73.27 (52.30%)	11.68M
NRXPNRX Pharmaceuticals Inc	$ 3.05 (45.24%)	9.31M
LYRALyra Therapeutics Inc	$ 0.519 (-87.12%)	108.65M
GLYCGlycoMimetics Inc	$ 0.3165 (-82.70%)	41M
EYPTEyePoint Pharmaceuticals Inc	$ 11.15 (-43.52%)	9.65M
LGHLWLion Group Holding Ltd	$ 0.0047 (-32.86%)	100.74k
MMATMeta Materials Inc	$ 2.44 (-27.16%)	580.58k
LYRALyra Therapeutics Inc	$ 0.519 (-87.12%)	108.65M
SQQQProShares UltraPro Short QQQ	$ 10.70 (-3.43%)	94.71M
NKLANikola Corporation	$ 0.6497 (-1.19%)	89.11M
MARAMarathon Digital Holdings Inc	$ 20.695 (18.12%)	87.05M
TSLATesla Inc	$ 184.76 (1.97%)	84.41M